Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001367644-25-000012
Filing Date
2025-02-11
Accepted
2025-02-11 16:01:31
Documents
1
Period of Report
2025-02-09

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1739307685.html 4  
1 FORM 4 wk-form4_1739307685.xml 4 3235
  Complete submission text file 0001367644-25-000012.txt   4636
Mailing Address 300 PROFESSIONAL DR GAITHERSBURG MD 20879
Business Address 300 PROFESSIONAL DR GAITHERSBURG MD 20879 240-631-3200
Emergent BioSolutions Inc. (Issuer) CIK: 0001367644 (see all company filings)

EIN.: 141902018 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 300 PROFESSIONAL DRIVE GAITHERSBURG MD 20879
Business Address
Perl Jessica (Reporting) CIK: 0002043716 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33137 | Film No.: 25609680